Wen, X., Wen, X., Shen, J., Shen, J., Miglio, M. R. D., Zeng, D., . . . Sechi, L. A. (2023). Endogenous retrovirus group FRD member 1 is a potential biomarker for prognosis and immunotherapy for kidney renal clear cell carcinoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationWen, Xiaofen, Xiaofen Wen, Jiaxin Shen, Jiaxin Shen, Maria Rosaria De Miglio, De Zeng, Leonardo A. Sechi, and Leonardo A. Sechi. Endogenous Retrovirus Group FRD Member 1 Is a Potential Biomarker for Prognosis and Immunotherapy for Kidney Renal Clear Cell Carcinoma. Frontiers Media S.A, 2023.
MLA (9th ed.) CitationWen, Xiaofen, et al. Endogenous Retrovirus Group FRD Member 1 Is a Potential Biomarker for Prognosis and Immunotherapy for Kidney Renal Clear Cell Carcinoma. Frontiers Media S.A, 2023.